SCHEMBL4250746

SCHEMBL4250746

NC(=O)C1Cc2ccccc2N(CC(=O)N2CCOCC2)C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
ALDH1A1 P00352 5/20 0.47
GAA P10253 4/20 0.47
KDM4E B2RXH2 3/20 0.46
MAPT P10636 3/20 0.46
TP53 P04637 1/20 0.46
THRB P10828 1/20 0.46
ALOX12 P18054 1/20 0.46
MAPK1 P28482 1/20 0.46
ATM Q13315 1/20 0.46
HTT P42858 2/20 0.45
POLB P06746 2/20 0.45
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
TSHR P16473 2/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4075144 0.90 CHRM2 (0.51) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL4075040 0.90 CHRM2 (0.54) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL4066622 0.86 CHRM2 (0.46) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL4066758 0.86 PYGL (0.50) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL4250747 0.86 SMN1; SMN2 (0.55) MEN1KMT2ASMN1; SMN2ALDH1A1GAA
SCHEMBL4064769 0.84 PYGL (0.49) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL4069396 0.82 CHRM2 (0.47) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL4072863 0.81 L3MBTL1 (0.46) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL4073094 0.81 CHRM2 (0.49) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL4068434 0.79 TSHR (0.44) MEN1KMT2ASMN1; SMN2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LIMITED (GB) 2009-04-16 US disclosed
EP-1819332-B1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LTD (GB) 2009-03-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PC, GOT2, PDK1 MEN1 4007/4885KMT2A 2295/4885SMN1; SMN2 3651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.